alpha-cyano-4-hydroxycinnamate has been researched along with Colorectal Neoplasms in 1 studies
alpha-cyano-4-hydroxycinnamate: specific inhibitor of pyruvate transport in rat liver mitochondria & human erythrocytes; structure
Colorectal Neoplasms: Tumors or cancer of the COLON or the RECTUM or both. Risk factors for colorectal cancer include chronic ULCERATIVE COLITIS; FAMILIAL POLYPOSIS COLI; exposure to ASBESTOS; and irradiation of the CERVIX UTERI.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Nelson, GL | 1 |
Ronayne, CT | 1 |
Solano, LN | 1 |
Jonnalagadda, SK | 1 |
Jonnalagadda, S | 1 |
Rumbley, J | 1 |
Holy, J | 1 |
Rose-Hellekant, T | 1 |
Drewes, LR | 1 |
Mereddy, VR | 1 |
1 other study available for alpha-cyano-4-hydroxycinnamate and Colorectal Neoplasms
Article | Year |
---|---|
Development of Novel Silyl Cyanocinnamic Acid Derivatives as Metabolic Plasticity Inhibitors for Cancer Treatment.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cinnamates; Colorectal Neoplas | 2019 |